Chung-Pin Li, M.D., Ph.D.

Degree:

M.D., School of Medicine, College of Medicine, National Yang Ming Chiao Tung University

Ph.D.

Institute of Clinical Medicine, College of Medicine, National Yang Ming Chiao Tung University

Post-doc fellow, Division of GI/Liver Pathology, Department of Pathology, Johns Hopkins University School of Medicine

Hospital Appointments:

Director and Attending Physician, Division of Clinical Skills Training, Department of Medical Education, Taipei Veterans General Hospital

Attending Physician, Division of Gastroenterology and Hepatology, Department of Medicine, Taipei Veterans General Hospital

Convener, Pancreatic Cancer Multi-specialty Team, Taipei Veterans General Hospital

Convener, TAS Teaching Evaluation System Working Group, Taipei Veterans General Hospital

Deputy Exam Director, OSCE, Taipei Veterans General Hospital

Deputy convener, PGY Working Group, Taipei Veterans General Hospital

Academic Appointments:

Professor, School of Medicine, College of Medicine, National Yang Ming Chiao Tung University

Past Appointments:

Associate Editor, "Clinical Medicine"

Executive Editor, Journal of Chinese Medical Association

Member and Deputy Executive Secretary, IRB, Taipei Veterans General Hospital

Deputy Executive Secretary, Human Research Protection Center, Taipei Veterans General Hospital

Deputy Convener, Cholangiocarcinoma Multi-specialty Team, Taipei Veterans General Hospital

Director, Gastroenterology and Hepatology Ward, Department of Medicine, Taipei Veterans General Hospital

Expertise:

Medical treatment of pancreatic cancer

Medical treatment of digestive system cancer

Treatment of chronic hepatitis B and C

Treatment of liver cirrhosis and its complications

Diagnosis and treatment of abdominal ultrasound and digestive tract endoscopy

Clinical skills training

Medical education

Office Address:

Division of Clinical Skills Training, Department of Medical Education, Taipei Veterans General Hospital, Taipei, Taiwan

E-mail:

cpli@vghtpe.gov.tw

Publications:

1. Su YY, Chiang NJ, Yang YH, Yen CJ, Bai LY, Chiu CF, Chuang SC, Yang SH, Chou WC, Chen JS, Chiu TJ, Chen YY, Chan DC, Peng CM, Chiu SC, Li CP* (correspondent), Shan YS*, Chen LT. Real-world data validation of NAPOLI-1 nomogram for the prediction of overall survival in metastatic pancreatic cancer. Cancers 2023, Feb., 15(4), 1008; https://doi.org/10.3390/cancers15041008 (Accepted: 31 January 2023 / Published: 5 February 2023).
2. Huang HC, Sung YC, Li CP (co-first author), Wan D, Chao PH, Cheng HT, Hsu FF, Huang CC, Liao YH, Hsieh HT, Shih YC, Liu IJ, Wu HC, Lu TT, Wang J, Chen Y. Reversal of Pancreatic Desmoplasia by a Tumor Stroma-targeted Nitric Oxide Nanogel Overcomes TRAIL Resistance in Pancreatic Tumors. Gut. 2022 Sep;71(9):1843-1855. doi: 10.1136/gutjnl-2021-325180. Epub 2021 Dec 17. (IF 31.795, R/C= 4/93, GASTROENTEROLOGY & HEPATOLOGY)
3. Chang YT, Yang YY, Li CP* (correspondent), Chen CH. Comparison between residents with a 6-year medical program and a 7-year medical program in terms of objective structured clinical examination performance in postgraduate year training in Taiwan: a 2-group pre- and post-test non-synchronized study. J Educ Eval Health Prof 2022; 19: 14. https://doi.org/10.3352/jeehp.2022.19.14. Epub 2022 Jun 24. (IF=1.96, R/C= 46/82, EDUCATION, SCIENTIFIC DISCIPLINES)
4. Yu HY, Lee CY, Lin LG, Chao Y, Li CP* (correspondent). Nanoliposomal irinotecan with 5-fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy: a real-world experience. J Chin Med Assoc. 2022 Jan 1;85(1):42-50. doi: 10.1097/JCMA.0000000000000650. (IF=3.396, R/C= 71/172, MEDICINE, GENERAL & INTERNAL)
5. Li CP (co-first author), Chen CC, Chen LL, Hsu YT, Jiang SS, Fan CS, Chua KV, Huang SX, Shyr YM, Chen LT, Huang TS. Myeloid-Derived Macrophages and Secreted HSP90α Induce Pancreatic Ductal Adenocarcinoma Development. Oncoimmunology 2018 Jan. 9; 7(5), e1424612.(IF: 8.110, IMMUNOLOGY: 23/162)
6. Wu CY, Hu HY, Chou YJ, Huang N, Chou YC, Li CP* (correspondent). What constitutes normal hemoglobin concentrations among community-dwelling older adults? Journal of the American Geriatrics Society 2016 Jun;64(6):1233-41. (IF= 4.388；R/C= 2/32, GERONTOLOGY)
7. Wang JP, Wu CY, Hwang IH, Kao CH, Hung YP, Hwang SJ, Li CP* (correspondent). How different is the care of terminal pancreatic cancer patients in inpatient palliative care units and acute hospital wards? A nationwide population-based study. BMC Palliative Care 2016 Jan 8;15(1):1 (IF=1.602, R/C= 46/88, HEALTH CARE SCIENCES & SERVICES).
8. Chen MH, Lin J, Hsiao CF, Shan YS, Chen YC, Chen LT, Liu TW, Li CP* (correspondent), Chao Y. A Phase II Study of Sequential Capecitabine plus Oxaliplatin Followed by Docetaxel plus Capecitabine in Patients with Unresectable Gastric Adenocarcinoma: The TCOG 3211 Clinical Trial. Medicine 2016 Jan;95(3):e2565 (IF=1.804, R/C= 40/155, Medicine, General & Internal).
9. Wu CY, Hu HY, Chou YJ, Huang N, Chou YC, Li CP* (correspondent). High Blood Pressure and All-cause and Cardiovascular Disease Mortalities in Community-dwelling Older Adults. Medicine 2015 Nov;94(47):e2160 (IF=1.804, R/C= 40/155, Medicine, General & Internal).
10. Wu CY, Hu HY, Chou YJ, Huang N, Chou YC, MS Lee, Li CP* (correspondent). High Serum Uric Acid Levels Are Associated with All-Cause and Cardiovascular, but Not Cancer, Mortality in Elderly Adults. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY 2015 Sep;63(9):1829-36. doi: 10.1111/jgs.13607. Epub 2015 Aug 16. (IF=4.388；R/C= 2/32, GERONTOLOGY)
11. Wu CY, Hu HY, Chow LH, Chou YJ, Huang N, Wang PN, Li CP* (correspondent). The effects of anti-dementia and nootropic treatments on the mortality of patients with dementia: a population-based cohort study in Taiwan. PLOS ONE 2015 Jun 22;10(6):e0130993. doi: 10.1371/journal.pone.0130993. (IF= 3.234；R/C= 9/57, Multidiscipline Medicine)
12. Wu CY, Chang WP, Chang YH, Li CP* (correspondent), Chuang CM. The risk of irritable bowel syndrome in patients with endometriosis during a 5-year follow-up: a nationwide population-based cohort study. International Journal of Colorectal Disease 2015 Jul;30(7):907-12. 2015 Apr 28. (IF= 2.449；R/C= 55/198, 27.8%, Surgery)
13. Wang JP, Wu CY, Yeh YC, Shyr YM, Wu YY, Kuo CY, Hung YP, Chen MH, Lee WP, Luo JC, Chao Y, Li CP* (correspondent). Erlotinib is effective in pancreatic cancer with epidermal growth factor receptor mutations: a randomized, open-label, prospective trial. Oncotarget 2015 Jul 20;6(20):18162-73. (IF= 5.008；R/C= 36/213, Oncology) (V103C-201, NSC 98-2314-B-075-029)
14. Wu CY, Hu HY, Chou YC, Huang N, Chou YJ, Li CP* (correspondent). The association of physical activity with all-cause, cardiovascular, and cancer mortality among older adults. Preventive Medicine 2015 Mar;72:23-9. (IF= 3.434；R/C= 24/155, MEDICINE, GENERAL & INTERNAL)
15. Wang JP, Kao FY, Wu CY, Hung YP, Chao Y, Chou YJ, Li CP* (correspondent). Nucleos(t)ide analogs associated with a reduced risk of hepatocellular carcinoma in hepatitis B patients: a population-based cohort study. Cancer 2015 May 1;121(9):1446-55. (IF= 5.649；R/C=26/213, ONCOLOGY)
16. Wu CY, Chou YC, Huang N, Chou YJ, Hu HY, Li CP* (correspondent). Cognitive impairment predicts mortality among the elderly assessed at annual geriatric health examinations. Preventive Medicine 2014 Oct;67:28-34. (IF= 2.932；R/C= 25/156, MEDICINE, GENERAL & INTERNAL)
17. Kuo CY, Chao Y, Li CP* (correspondent). Update treatment of gastric cancer. J Chin Med Assoc 2014 Jun 3;77:345-353. (I F=0.889；R/C= 96/156，MEDICINE, GENERAL & INTERNAL)
18. Chao Y, Hsieh JS, Yeh HT, Su YC, Wu CC, Chen JS, Tai CJ, Bai LY, Yeh KH, Su WC, Li CP* (correspondent). A multicenter phase II study of biweekly capecitabine in combination with oxaliplatin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer. Cancer Chemotherapy and Pharmacology 2014 April;73(4):799–806. (NSC 98-2314-B-075-029, VGH 101C-178, the National Research Program for Biopharmaceutics of Taiwan 100CT202) (I F=2.737；R/C= 112/257, PHARMACOLOGY & PHARMACY)
19. Wu CY, Hu HY, Huang N, Fang YT, Chou YJ, Li CP* (correspondent). Determinants of Long-term Care Services Among the Elderly: A Population-based Study in Taiwan. PLOS ONE 2014 Feb 19;9(2):e89213. (IF= 3.534；R/C= 8/55, Multidiscipline Medicine)
20. Wu CY, Hu HY, Chen L, Huang N, Chou YJ, Li CP* (correspondent). Investigating the utilization of radiological services by physician patients: a population-based cohort study in Taiwan. BMC Health Services Research. 2013 Jul:13:284. (IF= 1.712；R/C= 42/89, 47.2%, HEALTH CARE SCIENCES & SERVICES)
21. Chao Y, Wu CY, Wang JP, Lee RC, Lee WP, Li CP* (correspondent). A randomized controlled trial of gemcitabine plus cisplatin versus gemcitabine alone in the treatment of metastatic pancreatic cancer. Cancer Chemotherapy and Pharmacology 2013 Sep;72(3):637-42. (NSC 98-2314-B-075-029, VGH 101C-178, the National Research Program for Biopharmaceutics of Taiwan 100CT202) (I F=2.769；R/C= 98/254, 38.6%, PHARMACOLOGY & PHARMACY)